Clinical trial
Improvement of Left Ventricular Ejection Fraction in ICD Patients Undergoing Therapy With Sacubitril/Valsartan and Potential Impact on ICD Implant Rates for Primary Prevention of Sudden Cardiac Death (SAVE-ICD)
NCT03935087 is registered in ClinicalTrials.gov with Azienda Ospedaliera Cardinale G. Panico as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Improvement of Left Ventricular Ejection Fraction in ICD Patients Undergoing Therapy With Sacubitril/Valsartan and Potential Impact on ICD Implant Rates for Primary Prevention of Sudden Cardiac Death (SAVE-ICD)
- Lead sponsor
- Azienda Ospedaliera Cardinale G. Panico
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 1, 2018
- Completion date
- June 30, 2019
- Enrollment
- 150 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.